-+ 0.00%
-+ 0.00%
-+ 0.00%

Gyre Therapeutics Q4 revenue rose 33% to USD 37.2 million as Q4 selling and marketing expense climbed 41% to USD 23.8 million

Reuters·03/12/2026 10:07:05

Please log in to view news